Status:
RECRUITING
Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Epileptic Encephalopathy
Eligibility:
All Genders
Brief Summary
Electrical activity emerges in the third trimester of pregnancy, plays an important role in the construction of cortical maps, and is impaired in patients with severe early epileptic encephalopathies ...
Eligibility Criteria
Inclusion
- Epilepsy beginning before 1 month of life, and requiring the initiation of anti-epileptic treatment
- Without occasional cause
- Without brain malformation explaining epilepsy
- No opposition from parents / guardians
- Possibility for parents to complete parent questionnaires
Exclusion
- Neonatal attacks of occasional cause (glycemic disorder, infection, etc.)
- Acquired neonatal epilepsy (post-anoxic encephalopathy, stroke sequelae, etc.)
- Neonatal epilepsy related to a brain malformation
Key Trial Info
Start Date :
March 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2032
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04802135
Start Date
March 6 2021
End Date
September 1 2032
Last Update
November 20 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France
2
CHU Bordeaux
Bordeaux, France
3
CHU Brest
Brest, France
4
CHRU Lille
Lille, France